Host |
Mouse |
Klon |
BC/44 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Reveal modified Citrate pH 6.0 |
Positivkontrolle |
Colon cancer |
Verdünnung |
- |
Isotyp |
Mouse IgG1 |
Lokalisation |
Nuclear |
MSH6
|
Biocare Medical |
BC/44 |
6 ml |
Ready-to-use |
CE/IVD |
AVI265G |
-
|
Host |
Rabbit |
Klon |
SP93 |
Format |
Concentrate |
Methode |
P, WB |
Vorbehandlung |
EDTA |
Positivkontrolle |
Rectal Carcinoma |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
A synthetic peptide corresponding to internal region of human MSH6 protein |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zytomed Systems GmbH |
SP93 |
0.5 ml |
Concentrate |
RUO |
513-3932 |
-
|
Host |
Rabbit |
Klon |
SP93 |
Format |
Concentrate |
Methode |
P, WB |
Vorbehandlung |
EDTA |
Positivkontrolle |
Rectal Carcinoma |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
A synthetic peptide corresponding to internal region of human MSH6 protein |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zytomed Systems GmbH |
SP93 |
1 ml |
Concentrate |
RUO |
513-3934 |
-
|
Host |
Mouse |
Klon |
BC19 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon cancer |
Verdünnung |
1:100 |
Isotyp |
Mouse IgG1 κ |
Verdünnung |
Human MSH6 recombinant protein |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Biocare Medical |
BC19 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3215A |
-
|
Host |
Mouse |
Klon |
BC19 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon cancer |
Verdünnung |
1:100 |
Isotyp |
Mouse IgG1 κ |
Verdünnung |
Human MSH6 recombinant protein |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Biocare Medical |
BC19 |
1 ml |
Concentrate |
CE/IVD |
ACI3215C |
-
|
Host |
Mouse |
Klon |
BC19 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon cancer |
Verdünnung |
- |
Isotyp |
Mouse IgG1 κ |
Verdünnung |
Human MSH6 recombinant protein |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Biocare Medical |
BC19 |
6 ml |
Ready-to-use |
CE/IVD |
API3215AA |
-
|
Host |
Mouse |
Klon |
44 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon Carcinoma, Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Diagnostic Biosystems |
44 |
1 ml |
Concentrate |
CE/IVD |
MOB429 |
-
|
Host |
Mouse |
Klon |
44 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon Carcinoma, Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Diagnostic Biosystems |
44 |
0.1 ml |
Concentrate |
CE/IVD |
MOB429-01 |
-
|
Host |
Mouse |
Klon |
44 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon Carcinoma, Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Diagnostic Biosystems |
44 |
0.5 ml |
Concentrate |
CE/IVD |
MOB429-05 |
-
|
Host |
Mouse |
Klon |
44 |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Colon Carcinoma, Tonsil |
Verdünnung |
- |
Isotyp |
Mouse |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Diagnostic Biosystems |
44 |
6 ml |
Ready-to-use |
CE/IVD |
PDM147 |
-
|
Host |
Monospecific Mouse |
Klon |
ZM99 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant fragment of human MSH6 protein (around aa 374-540) |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zeta Corporation |
ZM99 |
1 ml |
Concentrate |
CE/IVD |
Z2409ML |
-
|
Host |
Monospecific Mouse |
Klon |
ZM99 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
- |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant fragment of human MSH6 protein (around aa 374-540) |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zeta Corporation |
ZM99 |
7 ml |
Ready-to-use |
CE/IVD |
Z2409MP |
-
|
Host |
Monospecific Mouse |
Klon |
ZM99 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant fragment of human MSH6 protein (around aa 374-540) |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zeta Corporation |
ZM99 |
0.5 ml |
Concentrate |
CE/IVD |
Z2409MS |
-
|
Host |
Monospecific Mouse |
Klon |
ZM99 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant fragment of human MSH6 protein (around aa 374-540) |
Lokalisation |
Nucleus |
MSH6 (MutS homologue 6, Mismatch Repair Protein)
|
Zeta Corporation |
ZM99 |
0.1 ml |
Concentrate |
CE/IVD |
Z2409MT |
-
|
Host |
Mouse |
Klon |
ZM32 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Breast carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human milk-fat globule membranes (HMFGM) |
Lokalisation |
Cytoplasm |
MUC-1
|
Zeta Corporation |
ZM32 |
1.0 ml |
Concentrate |
CE/IVD |
Z2336ML |
-
|
Host |
Mouse |
Klon |
ZM32 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Breast carcinoma. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
Human milk-fat globule membranes (HMFGM) |
Lokalisation |
Cytoplasm |
MUC-1
|
Zeta Corporation |
ZM32 |
7 ml |
Ready-to-use |
CE/IVD |
Z2336MP |
-
|
Host |
Mouse |
Klon |
ZM32 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Breast carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human milk-fat globule membranes (HMFGM) |
Lokalisation |
Cytoplasm |
MUC-1
|
Zeta Corporation |
ZM32 |
0.5 ml |
Concentrate |
CE/IVD |
Z2336MS |
-
|
Host |
Mouse |
Klon |
ZM32 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Breast carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human milk-fat globule membranes (HMFGM) |
Lokalisation |
Cytoplasm |
MUC-1
|
Zeta Corporation |
ZM32 |
0.1 ml |
Concentrate |
CE/IVD |
Z2336MT |
-
|
Host |
Rabbit |
Klon |
ZR175 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Colon carcinoma |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Synthetic peptide representing a region on the Muc-2 glycoprotein |
Lokalisation |
cell membrane |
MUC-2
|
Zeta Corporation |
ZR175 |
0.1 ml |
Concentrate |
CE/IVD |
Z2702RT |
-
|
Host |
Rabbit |
Klon |
ZR201 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Colon |
Verdünnung |
1:100 |
Isotyp |
IgG |
Verdünnung |
Recombinant fragment (around aa1500-2000) of human MUC4 protein |
Lokalisation |
Cytoplasm |
MUC-4
|
Zeta Corporation |
ZR201 |
1 ml |
Concentrate |
CE/IVD |
Z2520RL |
-
|
Host |
Rabbit |
Klon |
ZR201 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Colon |
Verdünnung |
- |
Isotyp |
IgG |
Verdünnung |
Recombinant fragment (around aa1500-2000) of human MUC4 protein |
Lokalisation |
Cytoplasm |
MUC-4
|
Zeta Corporation |
ZR201 |
7 ml |
Ready-to-use |
CE/IVD |
Z2520RP |
-
|
Host |
Rabbit |
Klon |
ZR201 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Colon |
Verdünnung |
1:100 |
Isotyp |
IgG |
Verdünnung |
Recombinant fragment (around aa1500-2000) of human MUC4 protein |
Lokalisation |
Cytoplasm |
MUC-4
|
Zeta Corporation |
ZR201 |
0.5 ml |
Concentrate |
CE/IVD |
Z2520RS |
-
|
Host |
Rabbit |
Klon |
ZR201 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Colon |
Verdünnung |
1:100 |
Isotyp |
IgG |
Verdünnung |
Recombinant fragment (around aa1500-2000) of human MUC4 protein |
Lokalisation |
Cytoplasm |
MUC-4
|
Zeta Corporation |
ZR201 |
0.1 ml |
Concentrate |
CE/IVD |
Z2520RT |
-
|
Host |
Mouse |
Klon |
ZM148 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Gastric carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
M1 mucin preparation from the fluid of an ovarian mucinous cyst belonging to an O Le(a-b) patient |
Lokalisation |
Cell membrane |
MUC-5AC
|
Zeta Corporation |
ZM148 |
1.0 ml |
Concentrate |
CE/IVD |
Z2461ML |
-
|
Host |
Mouse |
Klon |
ZM148 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Gastric carcinoma. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
M1 mucin preparation from the fluid of an ovarian mucinous cyst belonging to an O Le(a-b) patient |
Lokalisation |
Cell membrane |
MUC-5AC
|
Zeta Corporation |
ZM148 |
7 ml |
Ready-to-use |
CE/IVD |
Z2461MP |
-
|
Host |
Mouse |
Klon |
ZM148 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Gastric carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
M1 mucin preparation from the fluid of an ovarian mucinous cyst belonging to an O Le(a-b) patient |
Lokalisation |
Cell membrane |
MUC-5AC
|
Zeta Corporation |
ZM148 |
0.5 ml |
Concentrate |
CE/IVD |
Z2461MS |
-
|
Host |
Mouse |
Klon |
ZM148 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Gastric carcinoma. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
M1 mucin preparation from the fluid of an ovarian mucinous cyst belonging to an O Le(a-b) patient |
Lokalisation |
Cell membrane |
MUC-5AC
|
Zeta Corporation |
ZM148 |
0.1 ml |
Concentrate |
CE/IVD |
Z2461MT |
-
|
Host |
Mouse |
Klon |
ZM89 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Stomach. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant fragment covering tandem repeats of human MUC-6 protein |
Lokalisation |
Cytoplasm |
MUC-6
|
Zeta Corporation |
ZM89 |
1.0 ml |
Concentrate |
CE/IVD |
Z2399ML |
-
|
Host |
Mouse |
Klon |
ZM89 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Stomach. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant fragment covering tandem repeats of human MUC-6 protein |
Lokalisation |
Cytoplasm |
MUC-6
|
Zeta Corporation |
ZM89 |
7 ml |
Ready-to-use |
CE/IVD |
Z2399MP |
-
|
Host |
Mouse |
Klon |
ZM89 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Stomach. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant fragment covering tandem repeats of human MUC-6 protein |
Lokalisation |
Cytoplasm |
MUC-6
|
Zeta Corporation |
ZM89 |
0.5 ml |
Concentrate |
CE/IVD |
Z2399MS |
-
|
Host |
Mouse |
Klon |
ZM89 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Stomach. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant fragment covering tandem repeats of human MUC-6 protein |
Lokalisation |
Cytoplasm |
MUC-6
|
Zeta Corporation |
ZM89 |
0.1 ml |
Concentrate |
CE/IVD |
Z2399MT |
-
|
Host |
Mouse |
Klon |
996/1 |
Format |
Purified |
Methode |
F, P, WB |
Positivkontrolle |
Normal colon |
Isotyp |
Mouse IgG1 |
Verdünnung |
MUC2 tandem repeat peptide |
MUC2 (Mucin 2)
|
Zytomed Systems GmbH |
996/1 |
200 µg |
Purified |
RUO |
613-0273 |
-
|
Host |
Mouse |
Klon |
Ccp58 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Synthetic peptide representing a region on the Muc-2 glycoprotein |
Lokalisation |
Cell membrane |
MUC2 (Mucin 2)
|
Zeta Corporation |
Ccp58 |
1 ml |
Concentrate |
CE/IVD |
Z2151ML |
-
|
Host |
Mouse |
Klon |
Ccp58 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
Synthetic peptide representing a region on the Muc-2 glycoprotein |
Lokalisation |
Cell membrane |
MUC2 (Mucin 2)
|
Zeta Corporation |
Ccp58 |
7 ml |
Ready-to-use |
CE/IVD |
Z2151MP |
-
|
Host |
Mouse |
Klon |
Ccp58 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Synthetic peptide representing a region on the Muc-2 glycoprotein |
Lokalisation |
Cell membrane |
MUC2 (Mucin 2)
|
Zeta Corporation |
Ccp58 |
0.5 ml |
Concentrate |
CE/IVD |
Z2151MS |
-
|
Host |
Mouse |
Klon |
Ccp58 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Colon carcinoma. |
Verdünnung |
1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Synthetic peptide representing a region on the Muc-2 glycoprotein |
Lokalisation |
Cell membrane |
MUC2 (Mucin 2)
|
Zeta Corporation |
Ccp58 |
0.1 ml |
Concentrate |
CE/IVD |
Z2151MT |
-
|
Host |
Rabbit |
Klon |
SP241 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Lung Adenocarcinoma |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
Synthetic peptide derived from the C-terminus of human MUC-4 protein |
Lokalisation |
Cell membrane, Cytoplasm |
MUC4 (Mucin 4)
|
Zytomed Systems GmbH |
SP241 |
0.1 ml |
Concentrate |
RUO |
513-5410 |
-
|
Host |
Rabbit |
Klon |
SP241 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Lung Adenocarcinoma |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
Synthetic peptide derived from the C-terminus of human MUC-4 protein |
Lokalisation |
Cell membrane, Cytoplasm |
MUC4 (Mucin 4)
|
Zytomed Systems GmbH |
SP241 |
0.5 ml |
Concentrate |
RUO |
513-5412 |
-
|
Host |
Rabbit |
Klon |
SP241 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Lung Adenocarcinoma |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
Synthetic peptide derived from the C-terminus of human MUC-4 protein |
Lokalisation |
Cell membrane, Cytoplasm |
MUC4 (Mucin 4)
|
Zytomed Systems GmbH |
SP241 |
1 ml |
Concentrate |
RUO |
513-5414 |
-
|
Host |
Mouse |
Klon |
45M1 |
Format |
Concentrate |
Methode |
F, P |
Positivkontrolle |
Stomach |
Verdünnung |
1:50 - 1:75 |
Isotyp |
Mouse IgG1 kappa |
Lokalisation |
Cytoplasmic, Cell Surface |
MUC5AC (Mucin 5AC)
|
Diagnostic Biosystems |
45M1 |
1 ml |
Concentrate |
CE/IVD |
MOB357 |
-
|
Host |
Mouse |
Klon |
45M1 |
Format |
Concentrate |
Methode |
F, P |
Positivkontrolle |
Stomach |
Verdünnung |
1:50 - 1:75 |
Isotyp |
Mouse IgG1 kappa |
Lokalisation |
Cytoplasmic, Cell Surface |
MUC5AC (Mucin 5AC)
|
Diagnostic Biosystems |
45M1 |
0.1 ml |
Concentrate |
CE/IVD |
MOB357-01 |
-
|
Host |
Mouse |
Klon |
45M1 |
Format |
Concentrate |
Methode |
F, P |
Positivkontrolle |
Stomach |
Verdünnung |
1:50 - 1:75 |
Isotyp |
Mouse IgG1 kappa |
Lokalisation |
Cytoplasmic, Cell Surface |
MUC5AC (Mucin 5AC)
|
Diagnostic Biosystems |
45M1 |
0.5 ml |
Concentrate |
CE/IVD |
MOB357-05 |
-
|
Host |
Mouse |
Klon |
45M1 |
Format |
Ready-to-use |
Methode |
F, P |
Positivkontrolle |
Stomach |
Verdünnung |
- |
Isotyp |
Mouse IgG1 kappa |
Lokalisation |
Cytoplasmic, Cell Surface |
MUC5AC (Mucin 5AC)
|
Diagnostic Biosystems |
45M1 |
6 ml |
Ready-to-use |
CE/IVD |
PDM163 |
-
|
Host |
Mouse |
Klon |
45M1 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
EDTA o Citrate |
Positivkontrolle |
Stomach |
Verdünnung |
1:100 |
Isotyp |
Mouse IgM |
Verdünnung |
MUC5AC |
Lokalisation |
Cytoplasmic |
Mucin 5AC (Gastric Mucin)
|
Biocare Medical |
45M1 |
0.1 ml |
Concentrate |
CE/IVD |
CM231A |
-
|
Host |
Rabbit |
Klon |
BC5 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Nucleus, cytoplasm |
MUM-1 Protein
|
Biocare Medical |
BC5 |
0.1 ml |
Concentrate |
CE/IVD |
CRM352A |
-
|
Host |
Rabbit |
Klon |
BC5 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Nucleus, cytoplasm |
MUM-1 Protein
|
Biocare Medical |
BC5 |
0.5 ml |
Concentrate |
CE/IVD |
CRM352B |
-
|
Host |
Mouse |
Klon |
MUM1p |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm, nucleus |
MUM-1 Protein
|
Diagnostic Biosystems |
MUM1p |
1 ml |
Concentrate |
CE/IVD |
MOB420 |
-
|
Host |
Mouse |
Klon |
MUM1p |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm, nucleus |
MUM-1 Protein
|
Diagnostic Biosystems |
MUM1p |
0.1 ml |
Concentrate |
CE/IVD |
MOB420-01 |
-
|
Host |
Mouse |
Klon |
MUM1p |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm, nucleus |
MUM-1 Protein
|
Diagnostic Biosystems |
MUM1p |
0.5 ml |
Concentrate |
CE/IVD |
MOB420-05 |
-
|
Host |
Mouse |
Klon |
MUM1p |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
ready-to-use |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm, nucleus |
MUM-1 Protein
|
Diagnostic Biosystems |
MUM1p |
6 ml |
Concentrate |
CE/IVD |
PDM420 |
-
|